Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) (PETERPEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03671967
Recruitment Status : Recruiting
First Posted : September 14, 2018
Last Update Posted : October 22, 2020
Sponsor:
Collaborators:
Rabin Medical Center
University of Modena and Reggio Emilia
Tel Aviv Medical Center
Meir Medical Center
Soroka University Medical Center
The Chaim Sheba Medical Center
McGill University Health Centre/Research Institute of the McGill University Health Centre
Jewish General Hospital
Information provided by (Responsible Party):
Roni Oren MD, Rambam Health Care Campus